Epigenomics AG (FRA:ECX)
0.8900
0.00 (0.00%)
At close: Sep 26, 2025
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €783.99 thousand as of September 30, 2025. Its market cap has increased by 37.82% in one year.
Market Cap
783.99K
Enterprise Value
11.40M
Revenue
4.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.89
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 783.99K, a decrease of -98.49%. That is a compound annual growth rate of -31.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 29, 2025 | 783.99K | -20.01% |
Dec 30, 2024 | 980.17K | -38.24% |
Dec 29, 2023 | 1.59M | -76.50% |
Dec 30, 2022 | 6.75M | -17.48% |
Dec 30, 2021 | 8.18M | -57.46% |
Dec 30, 2020 | 19.23M | -68.09% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 262.21B |
Siemens Aktiengesellschaft | 177.42B |
Deutsche Telekom AG | 136.77B |
Allianz SE | 136.28B |
Rheinmetall AG | 89.95B |
Siemens Energy AG | 84.11B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.76B |
Deutsche Bank Aktiengesellschaft | 58.48B |